NeoGenomics (NEO) News Today $14.21 +0.23 (+1.65%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by AnalystsShares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and nine have given a buy recommeJanuary 19 at 4:53 AM | marketbeat.comNeoGenomics: Strong Revenue Growth and Strategic Initiatives Underpin Buy Rating Amidst Management ChangesJanuary 17 at 4:48 AM | markets.businessinsider.comBenchmark Co. Sticks to Its Hold Rating for NeoGenomics (NEO)January 16, 2025 | markets.businessinsider.comBenchmark retains Hold on Neogenomics stock, raises 2025 revenue forecastJanuary 16, 2025 | msn.comNeoGenomics: Balancing Promising Growth Prospects with Market Uncertainties and Valuation ConcernsJanuary 16, 2025 | markets.businessinsider.comFort Myers-based cancer lab expects strong performance in 2025, with new CEOJanuary 16, 2025 | msn.comNeoGenomics sees FY25 revenue $735M-$745M, consensus $727.9MJanuary 15, 2025 | markets.businessinsider.comNeoGenomics: Strong Financial Outlook and Strategic Growth Justify Buy RatingJanuary 15, 2025 | markets.businessinsider.comNeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial PlanJanuary 15, 2025 | finance.yahoo.comNeoGenomics rises on upbeat sales outlook for 2025January 15, 2025 | msn.comNeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term GuidanceJanuary 15, 2025 | yahoo.comNeoGenomics (NASDAQ:NEO) Shares Gap Up - Time to Buy?NeoGenomics (NASDAQ:NEO) Shares Gap Up - Time to Buy?January 15, 2025 | marketbeat.comNeoGenomics management to meet with Piper SandlerJanuary 15, 2025 | markets.businessinsider.comAdaptive Biotech Teams Up With NeoGenomics To Advance MRD Monitoring OptionsJanuary 14, 2025 | markets.businessinsider.comAdaptive, NeoGenomics partner to expand access to disease monitoringJanuary 14, 2025 | msn.comAdaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer PatientsJanuary 14, 2025 | finance.yahoo.comNeoGenomics (NASDAQ:NEO) Hits New 52-Week Low - Time to Sell?NeoGenomics (NASDAQ:NEO) Hits New 12-Month Low - Time to Sell?January 14, 2025 | marketbeat.comBenchmark Downgrades NeoGenomics (NEO)January 14, 2025 | msn.comNeoGenomics (NEO) was downgraded to a Hold Rating at Benchmark Co.January 13, 2025 | markets.businessinsider.comNeoGenomics downgraded to Hold at Benchmark on below-peer marginsJanuary 13, 2025 | markets.businessinsider.comNeoGenomics (NASDAQ:NEO) Trading Down 8% - Here's What HappenedNeoGenomics (NASDAQ:NEO) Trading Down 8% - Should You Sell?January 13, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Downgraded by Benchmark to HoldBenchmark lowered NeoGenomics from a "buy" rating to a "hold" rating in a research report on Monday.January 13, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Shares Gap Down - Here's WhyJanuary 12, 2025 | americanbankingnews.comNeoGenomics Maintains Buy Rating Amid Leadership Changes and Strategic Focus ShiftJanuary 12, 2025 | markets.businessinsider.comNeoGenomics price target lowered to $18 from $21 at BTIGJanuary 12, 2025 | msn.comNeoGenomics Shares Fall on CEO's Plan to RetireJanuary 11, 2025 | marketwatch.comFort Myers-based cancer lab NeoGenomics announces new CEOJanuary 11, 2025 | msn.comLeerink Partnrs Boosts Earnings Estimates for NeoGenomicsJanuary 11, 2025 | americanbankingnews.comNeoGenomics CEO Chris Smith to Retire; Tony Zook to Take HelmJanuary 10, 2025 | marketwatch.comNeoGenomics Shares Are Falling Today: What's Going On?January 10, 2025 | benzinga.comNeoGenomics' (NEO) Buy Rating Reiterated at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $19.00 target price on shares of NeoGenomics in a research report on Friday.January 10, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Shares Gap Down - Time to Sell?NeoGenomics (NASDAQ:NEO) Shares Gap Down - Here's What HappenedJanuary 10, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Releases FY 2024 Earnings GuidanceNeoGenomics (NASDAQ:NEO) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.080-0.100 for the period, compared to the consensus estimate of 0.100. The company also issued revenue guidance of $655.0 millionillion-$667.0 millionillion, compared to the consensus estimate of $662.0 millionillion.January 10, 2025 | marketbeat.comLeerink Partnrs Weighs in on NeoGenomics FY2024 EarningsNeoGenomics, Inc. (NASDAQ:NEO - Free Report) - Investment analysts at Leerink Partnrs raised their FY2024 earnings per share estimates for shares of NeoGenomics in a research report issued to clients and investors on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now anticipates that theJanuary 9, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Sets New 12-Month High - Should You Buy?NeoGenomics (NASDAQ:NEO) Hits New 52-Week High - Here's WhyJanuary 9, 2025 | marketbeat.comNEO Battery Materials Unveils Breakthrough Silicon Battery Capacity, Expanding to Space Industry with Solid-State BatteriesJanuary 7, 2025 | globenewswire.comNeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | businesswire.comStocks To Watch: NeoGenomics Sees RS Rating Jump To 81December 27, 2024 | msn.comIBD Rating Upgrades: NeoGenomics Flashes Improved Price StrengthDecember 26, 2024 | msn.comNeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have been given an average rating of "Moderate Buy" by the eleven research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. TheDecember 25, 2024 | marketbeat.comGeode Capital Management LLC Grows Position in NeoGenomics, Inc. (NASDAQ:NEO)Geode Capital Management LLC boosted its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 1.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,051,806 shares of the medical research cDecember 24, 2024 | marketbeat.comBarclays PLC Has $3.41 Million Position in NeoGenomics, Inc. (NASDAQ:NEO)Barclays PLC cut its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 24.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 230,901 shares of the medical research company's stock after selling 75,782 sharesDecember 24, 2024 | marketbeat.comNEO Battery Materials and Specialty Automotive Battery Cell Manufacturer Sign Joint Development Agreement for Silicon-Enhanced Battery TechnologyDecember 19, 2024 | globenewswire.comFranklin Resources Inc. Raises Stake in NeoGenomics, Inc. (NASDAQ:NEO)Franklin Resources Inc. boosted its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 2.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,043,840 shares of the medical research company's stock after buyingDecember 19, 2024 | marketbeat.comState Street Corp Has $73.14 Million Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)State Street Corp increased its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 1.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,958,582 shares of the medical research company's stock aDecember 18, 2024 | marketbeat.comNeoGenomics Shows Rising Relative Strength; Still Shy Of Key ThresholdDecember 17, 2024 | msn.comNeoGenomics price target raised to $19 from $18 at BofADecember 14, 2024 | markets.businessinsider.comBank of America Raises NeoGenomics (NASDAQ:NEO) Price Target to $19.00Bank of America lifted their price objective on shares of NeoGenomics from $18.00 to $19.00 and gave the company a "neutral" rating in a research report on Friday.December 13, 2024 | marketbeat.comJefferies Initiates Coverage of NeoGenomics (NEO) with Buy RecommendationDecember 11, 2024 | msn.comNeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk MelanomaDecember 11, 2024 | finance.yahoo.com Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address NEO Media Mentions By Week NEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEO News Sentiment▼0.080.44▲Average Medical News Sentiment NEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEO Articles This Week▼194▲NEO Articles Average Week Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bilibili News WillScot Mobile Mini News MARA News Etsy News QXO News Lyft News TriNet Group News Frontdoor News CarGurus News Payoneer Global News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEO) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEO Stock Alerts